Merck & Co., Inc. (NEO:MRK)

Canada flag Canada · Delayed Price · Currency is CAD
19.25
-0.12 (-0.62%)
Jul 28, 2025, 9:30 AM EDT
-0.62%
Market Cap289.55B
Revenue (ttm)91.88B
Net Income (ttm)25.06B
Shares Outn/a
EPS (ttm)9.89
PE Ratio11.55
Forward PE9.39
Dividendn/a
Ex-Dividend Daten/a
Volume100
Average Volume7,485
Open19.38
Previous Close19.37
Day's Range19.25 - 19.38
52-Week Range16.84 - 22.39
Betan/a
RSI58.87
Earnings DateJul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Cboe Canada
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.